Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levobupivacaine Infiltration for Episiotomy Pain
NCT02796547Phase 2Withdrawn
- Sponsor
- CHU Brugmann
- Start
- Jul 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of levobupivacaine in perineal pain, sponsored by CHU Brugmann. Planned start Jul 2016; status: withdrawn.
02
Drugs
levobupivacaine
03
Conditions
perineal pain
Beyond the preview
Go deeper on NCT02796547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02796547.